Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of novel biomarkers in prostate cancer diagnosis and prognosis
Wenji Li, Wei Xu, Kai Sun, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 9
Closed Access | Times Cited: 13

Showing 13 citing articles:

Curcumin inhibits prostate cancer by upregulating miR‐483‐3p and inhibiting UBE2C
Wenji Li, Fujun Wang, Xiaoxiang Wang, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 11
The Long and the Short of It: NEAT1 and Cancer Cell Metabolism
Nadine E. Smith, Phaedra Spencer-Merris, Archa H. Fox, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4388-4388
Open Access | Times Cited: 19
Role of non-coding RNA in the regulation of Centromere Protein F and ATPase family AAA domain containing 2 in tumorgenesis - A systemic review
Issam AbuQeis, Abeer A. Teeti, Ting‐Hua Wang
New discovery. (2025), pp. 1-8
Closed Access
Exploring BIRC family genes as prognostic biomarkers and therapeutic targets in prostate cancer
Xiaoxiang Yu, Yi Liu, Zeng-mi Mo, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers
Zongpan Ke, Xuechun Hu, Yixun Liu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104275-104275
Closed Access | Times Cited: 3
Prostate cancer: Novel genetic and immunologic biomarkers
Mohammad Samare‐Najaf, Hosein Kouchaki, Seyed Moein Mahini, et al.
Clinica Chimica Acta (2024) Vol. 555, pp. 117824-117824
Closed Access | Times Cited: 3
Bisphenol S enhances the cell proliferation ability of prostate cancer cells by regulating the expression of SDS
Guanqun Ju, Xiangyang Zhan, Xinglin Chen, et al.
Toxicology in Vitro (2024) Vol. 98, pp. 105827-105827
Closed Access | Times Cited: 2
Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma
Maurício Rocha Dourado, Amr Elseragy, Bruno Cesar da Costa, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 6
Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer
Xiaobo Wu, Xingbo Long, Chenkai Ma, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13873-13873
Open Access | Times Cited: 6
Urinary MicroRNA-21 for Prostate Cancer Detection Using a Silver Nanoparticle Sensor: A Promising Diagnostic Tool
See‐Tong Pang, Yueh-Er Chiou, Jasmine Lim, et al.
Biosensors (2024) Vol. 14, Iss. 12, pp. 599-599
Open Access
A Novel Prognostic Biomarker CENPF in Papillary Renal Cell Carcinoma
Ping Yang, Hongci Chen, Huiyun Pu, et al.
(2024), pp. 133-146
Closed Access
[miR-218-5p Targeting TPX2 Regulates p53 Pathway and Inhibits Malignant Progression of Lung Adenocarcinoma].
Jiangong Xu
PubMed (2023) Vol. 26, Iss. 10, pp. 721-731
Closed Access | Times Cited: 1
FOXD2-AS1 inhibits the proliferation and migration in prostate cancer: an in vitro and in vivo study
Xiong Mei, Yongli Nie, Jun Chen, et al.
Journal of Men s Health (2023)
Open Access
Page 1

Scroll to top